Brickell Biotech Inc (NASDAQ:BBI)
| 0.6602 Delayed Data As of Nov 27 |  +0.0138 / +2.11%Today’s Change | 0.47 Today|||52-Week Range 3.98 | -55.99% Year-to-Date |
Latest BBI News | Press Releases
No recent news for Brickell Biotech Inc.
Today’s Trading
| Previous close | 0.66 |
| Today’s open | 0.70 |
| Day’s range | 0.66 - 0.70 |
| Volume | 3,135,653 |
| Average volume (3 months) | 2,227,251 |
| Market cap | $35.4M |
Data as of 12:57pm ET, 11/27/2020
Growth & Valuation
| Earnings growth (last year) | +13.62% |
| Earnings growth (this year) | +84.22% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +388.10% |
| P/E ratio | NM |
| Price/Sales | 0.57 |
| Price/Book | 0.74 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| MLNDMillendo Therapeutic... | +0.15 | +8.67% |
| LIFEaTyr Pharma Inc | -0.04 | -1.11% |
| OPNTOpiant Pharmaceutica... | +0.21 | +2.54% |
| SLSSellas Life Sciences... | +0.17 | +4.79% |
Data as of 12:59pm ET, 11/27/2020
Financials
| Next reporting date | March 24, 2021 |
| EPS forecast (this quarter) | -$0.09 |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$23.9M |
| Net profit margin | -301.59% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Boulder, Colorado |
Forecasts
